mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0009 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.001 |
mRNA |
Dasatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.001 |
mRNA |
tivozanib |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.001 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.001 |
mRNA |
CHEMBL1222381 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.002 |
mRNA |
AGK-2 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |
mRNA |
decitabine |
CTRPv2 |
pan-cancer |
AAC |
-0.082 |
0.003 |
mRNA |
GSK461364 |
CTRPv2 |
pan-cancer |
AAC |
-0.093 |
0.003 |
mRNA |
lapatinib |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.004 |